Transforming Contraception and Oncofertility with AMH Insights – SSR
The Society for the Study of Reproduction (SSR) shared a post on LinkedIn:
“We are thrilled to announce the upcoming Roger V. Short Lecture featuring David Pépin at Harvard Medical School and 2025 Medal Recipient.
While reproductive innovation has remained largely unchanged for decades, Dr. Pépin’s lab is unlocking the power of Anti-Müllerian Hormone (AMH) to transform:
Contraception: Developing non-hormonal, long-term alternatives (including gene therapy in felines!).
Oncofertility: Protecting the ovarian reserve and uterine integrity during chemotherapy.
Aging: Understanding how ‘follicle pausing’ can improve long-term women’s health.
- When: Friday, March 6, 2026
- Time: 4:00 PM – 5:00 PM
- Where: Zoom
Don’t miss this deep dive into the translational pipeline of ovarian biology.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 7, 2026, 19:12Why Does Fertility Change After 38? – Fertility Plus
-
Aug 7, 2026, 19:01Sean Lauber: Does Sex Before or After Embryo Transfer Affect Implantation or Pregnancy?
-
Aug 7, 2026, 18:53Kiani Davis: What I Would Start With in the Fertility Patient Journey
-
Aug 7, 2026, 18:41Dalia Majedi: Key Factors in Choosing an IVF Clinic Abroad
-
Aug 7, 2026, 18:32Sarah Lewen: Carousel Fertility Is Built to Help Clinics Win the Next Decade
-
Aug 7, 2026, 18:14Masoud Zamani Esteki: The Key Knowledge Gaps in Modern Ovarian Biology
-
Aug 7, 2026, 18:01Jenny Gudge: New Opportunity for a Senior Fertility Nurse in Sussex
-
Aug 7, 2026, 17:37Clare Mansfield: I Don’t Think the Future of Fertility Care is Simply More Technology
-
Aug 7, 2026, 17:30Nevena Vidakovic: Reimagining the Future of Fertility at Merck
